Drug Approval | July 15, 2025
Zydus receives final approval from USFDA for Celecoxib Capsules
Celecoxib is a nonsteroidal anti-inflammatory drug
Celecoxib is a nonsteroidal anti-inflammatory drug
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
The company’s largest center for medical device applications, serving the entire Asian market
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
It is intended for contrast enhancement in MRI scans
Subscribe To Our Newsletter & Stay Updated
